Transvascular

company

About

Transvascular develops products for the treatment of coronary and peripheral vascular disease and congestive heart failure.

Details

Last Funding Type
Series D
Last Funding Money Raised
$10.80M
Industries
Health Care,Medical,Therapeutics
Operating Status
Active

Transvascular develops products for the treatment of coronary and peripheral vascular disease and congestive heart failure.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10.80M
Transvascular has raised a total of $10.80M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2002 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2002 Series D $10.80M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Transvascular is funded by 2 investors. Medtronic and Jomed NV are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series D
Jomed NV Series D